Concurrent validity of the Hamilton Depression rating scale and the Beck Depression Inventory versus the ICD-10 diagnostic criteria among patients with Parkinson's Disease

被引:0
|
作者
Serrano-Duenas, Marcos [1 ,2 ,3 ]
Sevilla, Sabrina [2 ]
Lastra, Paola [2 ]
机构
[1] Hosp Carlos Andrade Marin, Neurol Serv, Abnormal Movement Disorder Clin, Quito, Ecuador
[2] Pontif Catholic Univ Ecuador, Fac Med, Quito, Ecuador
[3] Natl Polytech Sch, Fac Sci, Dept Math, Quito, Ecuador
来源
REVISTA ECUATORIANA DE NEUROLOGIA | 2007年 / 16卷 / 03期
关键词
depression; Parkinson's disease; Hamilton Depression rating scale; Beck Depression Inventory; somatic items in depression; sensitiviy; specificity; NONMOTOR SYMPTOMS; SOMATIC SYMPTOMS; RELIABILITY; QUESTIONNAIRE; SEVERITY; IMPACT;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective: To examine the concurrent validity of the Hamilton Depression Rating Scale and the Beck Depression Inventory for quantifying depression in patients with Parkinson's disease, using the ICD-10 Diagnostic Criteria as the gold standard, and to determine if the somatization items considered are pertinent. Methods: The study involved one hundred and forty consecutive PD patients-102 men and 38 women- with a mean age of 68.7 years and mean disease duration of 6.7 years. Sensitivity, specificity, positive and negative predictive values and likelihood ratios were obtained with a 95% CI. ROC Curves (AUC) were also performed. Results: Based on ROC measurement of discriminative ability, our results suggest that both scales were poor at recognizing mild depression, somewhat better at recognizing moderate depression and adequate for distinguishing severe depression, though with poor specificity. Comparisons of HDRS-21, HDRS-12, BDI-21 and BDI-16 to determine concurrent validity all gave similar results for each depression level and no important differences between the complete scales (all 21 items) and abbreviated forms (without somatic items) were noted. Conclusions: We conclude that both scales possess similar psychometric properties, but our results cannot be compared with those of other studies that used DSM-IV criteria as their gold standard. These observations led to the following conclusions: (1) the evaluation scales and criteria that comprise them were not designed for PD; (2) the somatic items observed in our patients were a product of PD; and (3) as the severity of the illness increased, so did the number of items that were confused as elements of depression.
引用
收藏
页码:174 / 180
页数:7
相关论文
共 36 条
  • [31] Validity of the 30-item geriatric depression scale in patients with Parkinson's disease
    McDonald, William M.
    Holtzheimer, Paul E.
    Haber, Michael
    Vitek, Jerrold L.
    McWhorter, Kimberly
    DeLong, Mahlon
    MOVEMENT DISORDERS, 2006, 21 (10) : 1618 - 1622
  • [32] Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease
    Mahmoudi Asl, Aysan
    Mehdizadeh, Maryam
    Kulisevsky, Jaime
    Sabet, Azar
    Taghavi Azar Sharabiani, Parvaneh
    Mehdizadeh, Hajar
    Ashayeri, Hassan
    Taghizadeh, Ghorban
    DISABILITY AND REHABILITATION, 2022, 44 (10) : 2091 - 2098
  • [33] The degree of depression in Hamilton rating scale is correlated with the density of presynaptic serotonin transporters in 23 patients with Wilson's disease
    B. Eggers
    W. Hermann
    H. Barthel
    O. Sabri
    A. Wagner
    S. Hesse
    Journal of Neurology, 2003, 250 : 576 - 580
  • [34] The degree of depression in Hamilton, rating scale is correlated with the density of presynaptic serotonin transporters in 23 patients with Wilson's disease
    Eggers, B
    Hermann, W
    Barthel, H
    Sabri, O
    Wagner, A
    Hesse, S
    JOURNAL OF NEUROLOGY, 2003, 250 (05) : 576 - 580
  • [35] Rasch analysis of the Hospital Anxiety and Depression Scale among patients with early-stage Parkinson's disease
    Yang, H. J.
    Park, B. S.
    Park, J. Y.
    Lee, E. M.
    Kin, S. Y.
    Kim, W. J.
    Kwon, J. H.
    MOVEMENT DISORDERS, 2018, 33 : S838 - S839
  • [36] Improvement of depressive symptoms in patients with moderate-to-severe psoriasis treated with ustekinumab: an open label trial validated using beck depression inventory, Hamilton depression rating scale measures and 18fluorodeoxyglucose (FDG) positron emission tomography (PET)
    Kim, Seong-Jang
    Park, Min-Young
    Pak, Kyoungjune
    Han, Junhee
    Kim, Gun-Wook
    Kim, Hoon-Soo
    Ko, Hyun-Chang
    Kim, Moon-Bum
    Kim, Byung-Soo
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (08) : 761 - 768